Featuring: publicly traded & venture capital companies on the U.S. (NYSE, NASDAQ, AMEX & OTC: BB) and Canadian (TSX & TSX-V) stock exchanges, Investment & Money Management Ideas. |
|
|
Press Release - Provectus Pharmaceuticals, Inc. (PVCT-OCT: BB) |
|
|
We have solved the essential problem that other scientists and companies have not been able to solve; that is to make a cancer specific drug. We have found out how to make it simply, pragmatically and inexpensively; namely, to build it and make a very safe molecule. - Dr. H. Craig Dees, Ph.D. (PVCT) (Interview published April 12, 2007) |
The Most Powerful Name In Corporate News and Information. |
|
CURRENT ISSUE | COVER ARCHIVES | INDEX | CONTACT | FINANCIALS | MARKETING SERVICES | HOME PAGE |
|
Provectus News Video of Provectus
Presentation at the SCIA Summer Conference Available Craig Dees, Ph.D., CEO of Provectus Pharmaceuticals, discussed PV-10 for melanoma clinical development, potential broad-spectrum use of PV-10, and corporate highlights in a presentation made at the Southern California Investment Association Summer Conference on June 5, 2010. Video and slides from the presentation may be viewed on the SCIA website at http://www.sciaconference.com/PublicCo/June2010/PVCT/Index.html.
|
|
